HomeIPH • EPA
Innate Pharma SA
€1.82
Jan 15, 3:01:06 AM GMT+1 · EUR · EPA · Disclaimer
StockFR listed security
Previous close
€1.84
Day range
€1.80 - €1.84
Year range
€1.33 - €2.79
Market cap
158.53M EUR
Avg Volume
212.52K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
(EUR)Jun 2024Y/Y change
Revenue
6.17M-69.29%
Operating expense
4.79M4.79%
Net income
-12.38M-1,541.44%
Net profit margin
-200.60-4,797.89%
Earnings per share
——
EBITDA
-12.78M-1,007.13%
Effective tax rate
——
Total assets
Total liabilities
(EUR)Jun 2024Y/Y change
Cash and short-term investments
91.80M3.27%
Total assets
151.50M-23.89%
Total liabilities
122.70M-13.09%
Total equity
28.80M—
Shares outstanding
80.95M—
Price to book
5.12—
Return on assets
-21.71%—
Return on capital
-51.15%—
Net change in cash
(EUR)Jun 2024Y/Y change
Net income
-12.38M-1,541.44%
Cash from operations
1.52M126.48%
Cash from investing
466.00K478.86%
Cash from financing
-2.16M-247.27%
Net change in cash
-307.50K95.20%
Free cash flow
-7.03M-428.30%
About
Founded
1999
Employees
168
Search
Clear search
Close search
Google apps
Main menu